MGNX
#3465
MacroGenics, Inc. - Common Stock
4.0 1 USD
-0.02%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-1.72%
Monthly Change
+4.43%
6 month change
+104.59%
Year Change
+133.14%
Previous Close
4.0 8
Open
4.0 1
Low
4.0 0
High
4.0 6
Volume
74
Financials
- Market Capitalization 255.44 M
- Employee 293
- Founded 2000
- CEO N/A
- Website www.macrogenics.com
- Headquarter Delaware, United States
- FIGI BBG000BM2SF8
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.36
Price to sales ratio
0.68
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3456 |  NAGE Niagen Bioscience, Inc. - Common Stock | 3.29 USD | +2.49% | +3.46% | +0.61% | -33.94% | 260.32 M USD | ||
| 3461 |  YDES YD Bio Limited - Ordinary Shares | 3.65 USD | -5.68% | -23.16% | +72.17% | -54.37% | 258.38 M USD | ||
| 3476 |  CLLS Cellectis S.A. - American Depositary Shares | 3.51 USD | +2.63% | +4.78% | +23.16% | +33.46% | 251.85 M USD | ||
| 3484 |  CGEN Compugen Ltd. - Ordinary Shares | 2.62 USD | -5.07% | -2.24% | +14.91% | +87.14% | 247.73 M USD |
Frequently asked questions about MacroGenics, Inc.
What is the MacroGenics, Inc. stock price today?
The current price of MacroGenics, Inc. (MGNX) is 4.01. Over the past 24 hours, the stock has changed by -1.72%. Follow the MGNX chart for real-time price dynamics.
What is the stock ticker of MacroGenics, Inc.?
MacroGenics, Inc. trades under the ticker MGNX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is MacroGenics, Inc. stock going up?
MGNX has changed by -1.96% over the last week, +4.43% over the last month, and +133.14% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of MacroGenics, Inc.?
MacroGenics, Inc. currently has a market capitalization of 255.44 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were MacroGenics, Inc. earnings last quarter?
Last quarter, MacroGenics, Inc. reported earnings of 0.31 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was MacroGenics, Inc. revenue for the last quarter?
MacroGenics, Inc. reported quarterly revenue of 32.83 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was MacroGenics, Inc. net income for the last quarter?
MacroGenics, Inc. reported net income of 19.52 M for the last quarter. The previous quarter showed -36.77 M, which means net income changed by +153.07%.
How many employees does MacroGenics, Inc. have?
As of the latest available data, MacroGenics, Inc. has 293 employees. Workforce size can provide additional context about the company's scale and operations.
What is MacroGenics, Inc. EBITDA?
MacroGenics, Inc. EBITDA is -13.14 M, and its EBITDA margin is -40.03%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy MacroGenics, Inc. stock?
You can buy MacroGenics, Inc. (MGNX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in MacroGenics, Inc. stock?
Investing in MacroGenics, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the MGNX chart and related analysis on metatrader.com as part of your research.